NOMENKLATURA E KOMBINUAR E MALLRAVE 2012 - INSTAT
NOMENKLATURA E KOMBINUAR E MALLRAVE 2012 - INSTAT NOMENKLATURA E KOMBINUAR E MALLRAVE 2012 - INSTAT
Kodi NK CAS RN Emri 12/4/9002 urate oxidase 9003-98-9 deoxyribonuclease 3824 90 0-00-0 4-(2-aminoethylthiomethyl)-1,3-thiazol-2-ylmethyl(dimethyl)amine, in the form of a solution in toluene 0-00-0 alpha-(6-fluoro-2-methylinden-3-yl)-p-tolyl methyl sulfide, in the form of a solution in toluene 3824 90 64 0-00-0 Intermediate concentrate obtained from a genetically modified E. coli fermentation medium, containing human granulocyte-macrophage colony-stimulating factor; for use in the manufacture of medicaments of HS heading 3002 0-00-0 Intermediate concentrate obtained from a genetically modified E. coli fermentation medium, containing human interferon alpha-2b; for use in the manufacture of medicaments of HS heading 3002 0-00-0 Intermediate concentrates obtained from a Micromonospora inyoensis fermentation medium used for the manufacture of the antibiotics sisomicin (INN) and netilmicin (INN) 0-00-0 Intermediate concentrates obtained from a Micromonospora purpurea fermentation medium used for the manufacture of the antibiotics gentamicin sulfate (INNM) and isepamicin (INN) 0-00-0 potassium clavulanate--microcrystalline cellulose (1:1) 0-00-0 potassium clavulanate--silicon dioxide (1:1) 0-00-0 potassium clavulanate--sucrose (1:1) 330-95-0 1,3-bis(4-nitrophenyl)urea-4,6-dimethylpyrimidin-2-ol (1:1) 104832-01-1 (R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolinedibenzoyl-L-tartaric acid (1:1) 3824 90 97 0-00-0 ethyl 7-chloro-2-oxoheptanoate, in the form of a solution in toluene 30165-96-9 4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine, toluene solution 38345-66-3 (2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-ol, toluene solution 84449-81-0 4-[2-(piperidin-1-yl)ethoxy]benzoyl chloride hydrochloride, 1,2-dichloroethane solution 127852-28-2 (1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethan-1-ol, acetonitrile solution 170277-77-7 (3S)-3-[2-(mesyloxy)ethoxy]-4-(trityloxy)butyl methanesulfonate, dimethylformamide solution 3907 20 99 913976-27-9 poly(oxy-1,2-ethanediyl), -hydro- -methoxy, diester with 21N6, 21 N6-[[(N2, N6- dicarboxy-L-lysyl- -alanyl)imino]bis(1-oxo-2, 1-ethanediyl)]bis[N-acetylglycyl-Lleucyl-L-tyrosyl-L-alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-Lisoleucyl-L-threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl-L-glutaminyl-Lprolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamide] cyclic (6 15), (6 15 ) bis(disulfide) 3911 90 162430-94-6 1,6-hexanediamine, polymer with 1,10-dibromodecane
SHTOJCA 5 MALLRAT E PA PERDORSHME PER KONSUM NJEREZOR
- Page 803 and 804: Kodi NK CAS RN Emri 610300-07-7 (3S
- Page 805 and 806: Kodi NK CAS RN Emri 32981-85-4 meth
- Page 807 and 808: Kodi NK CAS RN Emri 376348-77-5 4,4
- Page 809 and 810: Kodi NK CAS RN Emri 130580-02-8 tra
- Page 811 and 812: Kodi NK CAS RN Emri 860035-07-0 1-{
- Page 813 and 814: Kodi NK CAS RN Emri 192704-56-6 11-
- Page 815 and 816: Kodi NK CAS RN Emri 959624-24-9 6-(
- Page 817 and 818: Kodi NK CAS RN Emri 2008-75-5 1-(2-
- Page 819 and 820: Kodi NK CAS RN Emri 84100-54-9 4-(e
- Page 821 and 822: Kodi NK CAS RN Emri 230615-59-5 7,8
- Page 823 and 824: Kodi NK CAS RN Emri 64228-78-0 pent
- Page 825 and 826: Kodi NK CAS RN Emri 3934-20-1 2,4-d
- Page 827 and 828: Kodi NK CAS RN Emri 145783-14-8 4,6
- Page 829 and 830: Kodi NK CAS RN Emri 2933 69 80 5890
- Page 831 and 832: Kodi NK CAS RN Emri 0-00-0 5-fluoro
- Page 833 and 834: Kodi NK CAS RN Emri 66242-82-8 diso
- Page 835 and 836: Kodi NK CAS RN Emri 143322-57-0 5-b
- Page 837 and 838: Kodi NK CAS RN Emri butyl ester mon
- Page 839 and 840: Kodi NK CAS RN Emri 115065-79-7 (2E
- Page 841 and 842: Kodi NK CAS RN Emri 833 6504-57-0 4
- Page 843 and 844: Kodi NK CAS RN Emri 70035-75-5 diph
- Page 845 and 846: Kodi NK CAS RN Emri 127111-98-2 dip
- Page 847 and 848: Kodi NK CAS RN Emri 186521-42-6 met
- Page 849 and 850: Kodi NK CAS RN Emri 521266-46-6 (2S
- Page 851 and 852: Kodi NK CAS RN Emri 149456-98-4 N-[
- Page 853: Kodi NK CAS RN Emri 4132-28-9 2,3,4
- Page 857 and 858: Nr Kodi NK Pershkrimi Denatyruesi E
Kodi NK CAS RN Emri<br />
12/4/9002 urate oxidase<br />
9003-98-9 deoxyribonuclease<br />
3824 90 0-00-0 4-(2-aminoethylthiomethyl)-1,3-thiazol-2-ylmethyl(dimethyl)amine, in the form of a<br />
solution in toluene<br />
0-00-0 alpha-(6-fluoro-2-methylinden-3-yl)-p-tolyl methyl sulfide, in the form of a solution in<br />
toluene<br />
3824 90 64 0-00-0 Intermediate concentrate obtained from a genetically modified E. coli fermentation<br />
medium, containing human granulocyte-macrophage colony-stimulating factor; for use<br />
in the manufacture of medicaments of HS heading 3002<br />
0-00-0 Intermediate concentrate obtained from a genetically modified E. coli fermentation<br />
medium, containing human interferon alpha-2b; for use in the manufacture of<br />
medicaments of HS heading 3002<br />
0-00-0 Intermediate concentrates obtained from a Micromonospora inyoensis fermentation<br />
medium used for the manufacture of the antibiotics sisomicin (INN) and netilmicin<br />
(INN)<br />
0-00-0 Intermediate concentrates obtained from a Micromonospora purpurea fermentation<br />
medium used for the manufacture of the antibiotics gentamicin sulfate (INNM) and<br />
isepamicin (INN)<br />
0-00-0 potassium clavulanate--microcrystalline cellulose (1:1)<br />
0-00-0 potassium clavulanate--silicon dioxide (1:1)<br />
0-00-0 potassium clavulanate--sucrose (1:1)<br />
330-95-0 1,3-bis(4-nitrophenyl)urea-4,6-dimethylpyrimidin-2-ol (1:1)<br />
104832-01-1 (R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolinedibenzoyl-L-tartaric<br />
acid (1:1)<br />
3824 90 97 0-00-0 ethyl 7-chloro-2-oxoheptanoate, in the form of a solution in toluene<br />
30165-96-9 4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine, toluene solution<br />
38345-66-3 (2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-ol, toluene solution<br />
84449-81-0 4-[2-(piperidin-1-yl)ethoxy]benzoyl chloride hydrochloride, 1,2-dichloroethane solution<br />
127852-28-2 (1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethan-1-ol, acetonitrile solution<br />
170277-77-7 (3S)-3-[2-(mesyloxy)ethoxy]-4-(trityloxy)butyl methanesulfonate, dimethylformamide<br />
solution<br />
3907 20 99 913976-27-9 poly(oxy-1,2-ethanediyl), -hydro- -methoxy, diester with 21N6, 21 N6-[[(N2, N6-<br />
dicarboxy-L-lysyl- -alanyl)imino]bis(1-oxo-2, 1-ethanediyl)]bis[N-acetylglycyl-Lleucyl-L-tyrosyl-L-alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-Lisoleucyl-L-threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl-L-glutaminyl-Lprolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamide]<br />
cyclic (6 15), (6 15 )<br />
bis(disulfide)<br />
3911 90 162430-94-6 1,6-hexanediamine, polymer with 1,10-dibromodecane